samedan logo
 
 
 
spacer
home > ebr > autumn 2001 > personalised medicine draws nearer
PUBLICATIONS
European Biopharmaceutical Review

Personalised Medicine Draws Nearer

What's your broad perspective on the uptake of pharmacogenomics to-date as a drug development activity, and how significant do you think this is for the industry? First of all, we have long believed that pharmacogenomics is really the first application of the genomics revolution. In other words, the first key products that will come out of the whole genomics field will be in the form of molecular diagnostics, based on determining genetic variability in patient response to drugs. We believe the pharmaceutical industry is now moving rapidly to incorporate pharmacogenomics across drug development activities. For example, in most clinical trials, DNA is being isolated and stored, to be queried later against genetic markers identifying which patients are responding to drugs.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Taylor Crouch joined Variagenics, Inc. in April 1999 with a distinguished track record in pharmaceutical marketing and clinical development. Formerly Senior Vice President for worldwide marketing and strategic development at the multinational CRO, PAREXEL International Corporation, he also spent 10 years in the pharmaceutical and device industries in new product development marketing at Schering Plough International, Pfizer International and Johnson & Johnson's Critikon Division. A man with a clear vision for the future of pharmacogenomics in the development and commercialisation of new medicines, Crouch spoke with Helen Abbott, Editor of EBR, about this brave new world.
spacer
Taylor Crouch
spacer
spacer
spacer
Dr Helen Abbott
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Clinical Researcher of the Year - The Americas 2021 winners announced

The winners of the 2021 Clinical Researcher of the Years – The Americas competition have been announced, with the exceptional talent of clinical researchers across the Americas recognised during a live virtual awards ceremony.
More info >>

White Papers

Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs

World Courier

With a fully integrated GxP-compliant transport, storage and distribution system in place and over 140 wholly owned ISO 9001 - certified offices in more than 50 countries, WORLD COURIER, an AmerisourceBergen® company, is the world’s largest and most experienced provider of specialty courier services. It is uniquely positioned to meet the most demanding industry requirements for managing the global distribution of time - and temperaturesensitive pharmaceutical products and IMPs used commercially or in clinical trials.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement